HIVE in the Media
Participants in a pre-exposure prophylaxis (PrEP) trial comparing TDF/FTC (Truvada) with a look-alike dummy pill aimed to take two pills 2 to 24 hours before sex, one pill 24 hours after the first two pills, and one pill 24 hours after the third pill.
Dr. Monica Hahn co-authored a piece called “Special Considerations: The Care of Women and Gender Variant Patients Living with HIV” in the October 2018 issue of HIV Specialist Magazine.
In honor of Father’s Day, we sat down with Shannon Weber, M.S.W., executive director of HIVE and Guy Vandenberg, M.S.W., RN, with the Positive Reproduction Options for Men (PRO Men) project of HIVE and Ward 86 in San Francisco.
Although men who have sex with other men are still most susceptible to HIV in the U.S., women nonetheless made up 19 percent of new diagnoses in 2016. Black women specifically are disproportionately affected by HIV, accounting for 61 percent of women living with the disease and 19 percent of new diagnoses, while making up only about 7 percent of the population.
The Chancellor Award for Public Service in the staff category was awarded to Shannon Weber, who has worked steadfastly on HIV prevention, care and treatment projects.
The prescription of HIV-prevention pills has lagged, and negative biases towards patients could help explain why.
It’s good news for HIV-affected couples and those who treat them: The U.S. Centers for Disease Control and Prevention (CDC) is, at long last, truly up-to-date on its HIV-affected conception guidance.
Family planning clinics provide key access points for many women to learn about and obtain PrEP. By incorporating PrEP services into family planning care, family planning providers have the opportunity to meet women’s expectations, ensure women are aware of and offered comprehensive HIV prevention options, and reverse emerging disparities in PrEP access.
Caroline Watson, who serves as the social justice and communications coordinator for UCSF’s HIVE clinic and program, was honored as a 2018 recipient of the Heroes & Hearts Award during an event at AT&T Park.
The 2018 heroes are Karen Aguilar, Lead Patient Navigator of Gender Health SF at San Francisco Department of Public Health, and Caroline Watson, Social Justice and Communications Coordinator at ZSFG’s HIVE.
In a Rare Series of Candid Conversations, Three Women of Color Open Up About Their Decisions to Take PrEP, the Challenges They Faced Along the Way, and the Impact Their Stories are Having in Their Communities.
Today, for people living with HIV, treatment of the virus that causes AIDS with antiretroviral therapy allows individuals to live longer, healthier and fuller lives. Among mixed status, or serodifferent, couples – where one partner has HIV and the other does not – suppression of the virus also prevents transmission.
In fact, a recent CDC report published this month notes that three multinational studies following about 3,000 sexually active mixed status couples over many years – where the partner living with HIV was virologically suppressed by ART, and condoms weren’t used – found no cases of transmission of the virus to the partner who didn’t have HIV.
HIVE intern Gaby Sandor blogs about her experiences in the summer of 2017.
HIV-affected couples and individuals who desire children should be offered options for safer conception.
Research demonstrates that “condomless sex” does not necessarily indicate “unprotected sex”: sustained use of antiretroviral therapy (ART) to achieve a suppressed viral load in partners living with HIV, known as treatment as prevention (TasP), is associated with zero or near-zero risk of sexual HIV transmission.
Confused by the CDC’s new MMWR? You are not alone. Experts say Treatment as Prevention (TasP), PrEP, and sperm washing are each safe stand-alone safer conception options. Thank you to AAHIVM for promoting science-based reproductive options! #HIVLoveWins #UequalsU
Expert: Long-Awaited CDC HIV Report on Conception Options for Serodiscordant Couples Is Disappointing and Confusing
We’re in the middle of a revolution in our efforts to fight HIV. However, you wouldn’t know it from a new Centers for Disease Control and Prevention (CDC) report that advises providers about conception when one partner is living with HIV.
Male involvement in reproductive health, defined as conversations between male/female couples regarding pregnancy desires or specific reproductive health interventions, is associated with women’s increased contraceptive use, male partner HIV testing, and condom use.
“Nobody thinks they’re at risk for HIV regardless of what they’re doing, and then you have these layers of shame,” Weber tells Teen Vogue. “So it has to be integrated into a wellness package.”
Many know that digital tools have become indispensable for connecting with many audiences—but we also know that what’s available in the digital realm is always changing. So how do you know what tools are best for your purpose? And how do you plan for your organization’s digital future when the pace of change is so rapid? Recently, we asked colleagues what advice they would give for developing a digital media strategy.
For Caroline Watson, it’s that fear and misinformation that’s spurring her ride. Caroline, who works at a nonprofit that focuses on advancing reproductive and sexual wellness for people with HIV, is riding for her friend, Ryan, who recently began taking medication to treat the illness.
Is pericoital or peri-insemination pre-exposure prophylaxis effective human immunodeficiency prevention for vaginal exposures?
In fact, there has never been a case reported of penile-vaginal HIV transmission in the setting of an undetectable viral load. Therefore, in these studies, HIV prevention was due to treatment as prevention and not subtherapeutically dosed PrEP.
Amidst fear, and with limited medical information about HIV, in 1988 California passed laws criminalizing the behavior of people living with HIV. These HIV criminalization laws have been counterproductive for individuals and public health – creating deep mistrust of public health systems.
HIVE’s Shannon Weber on 10 Percent TV with David Perry, discussing what’s changed in HIV care since the height of the epidemic, and how San Francisco is leading the way. #GettingToZeroSF #HIVLoveWins #TenPercent
Reporter Chloe Lessard of U.C. Berkeley speaks with some Bay Area women who also use PrEP.
HIVE Director Shannon Weber featured in Dutch glossy magazine hello gorgeous!
After initial persecution against those taking Truvada to prevent HIV infection, there’s been a positive shift in attitude toward the drug
Diggs became celibate about four years ago shortly after learning she had an undetectable viral load. She knows that because her load is suppressed the risk of transmission is negligible. But the ignorance and stigma she faces is not worth investing in dead-end hook ups when she wants a relationship, she said.
The HIV justice movement has radical roots. Advocacy, activism and sexual rights birthed this movement that was once about how larger structural systems affect people’s lives and sometimes, lead to their death. Today, on the other hand, transphobia, misogyny, racism and anti-blackness are well and alive within the world of HIV treatment and prevention. This has resulted in marginalized communities (African Americans, Latinos, trans women, cis and trans men who have sex with men/MSM) experiencing high rates of HIV.
Straight or gay, aspiring parents who have HIV in the mix have numerous options for conceiving a child without transmitting the virus.
BETA wanted to distill some of these important findings by asking some prominent San Francisco Bay Area HIV experts to give us their take on the International AIDS Conference. We asked, “What did you find interesting? What did you find exciting? And, what did you learn?”
While stuck in Washington DC traffic, a highly respected HIV researcher and a cab driver have time to chat. Both are Black women. Both are painfully aware of HIV.
PrEP is a disruptive innovation in the HIV prevention dialogue, introducing choice and the possibility for shared decision-making. We have the opportunity to develop a prevention approach responsive to women’s reproductive and sexual preferences and values across a lifetime. Let’s take advantage of it.
One in four U.S. women have experienced gender based violence. Among women living with HIV, one in two has experienced intimate partner violence, and more than 60% have been sexually abused – 5 times the rate of the general female population.
In 1983 the US Food and Drug Administration (FDA) issued a ban on sperm donation from “any men who have had sex with another man in the preceding five years” to prevent HIV transmission to a surrogate or gestational carrier.
More and more, individuals are learning about the potential impact of HIV pre-exposure prophylaxis (PrEP). As awareness grows, so does the number of individuals seeking providers with whom they can discuss this highly effective HIV-prevention tool.
Three existing initiatives, New York State’s End AIDS NY 2020, Washington State’s End AIDS Washington, and the City of San Francisco’s Getting to Zero SF, gathered in conversation to discuss similarities and differences in their approaches as well as spark dialogue with other jurisdictions contemplating their own initiatives. Here is some of what was discovered.
“PrEP is something revolutionary for everyone, but essential for gay and bisexual youth; so many [young people] are exposed to STIs and HIV simply due to lack of information about PrEP. ‘A pill a day will keep HIV away’, I like to tell my friends.”
The report focuses on what Black communities need to know about pre-exposure prophylaxis (PrEP) and other new biomedical HIV prevention tools.
The focus group conversations gripped me. I could not sleep at night, wrestling with the stories of trauma, shame and guilt the men shared. As the stories rattled me and the focus group participants, a new narrative began to unfold: reclaiming an old story of HIV to creating a new horizon of possibility and hope.
The babies’ father, Aiden*, is HIV positive (a fact that remains unknown to most of the couple’s loved ones), but with medication, Zoey was able to remain virus-free and successfully conceive and deliver two perfectly healthy babies with Aiden.
Three-and-a-half years ago, the U.S. Food and Drug Administration approved the HIV treatment drug Truvada as pre-exposure prophylaxis or PrEP for HIV prevention. It was a landmark moment in the decades-long effort to halt HIV transmission. This pill, when taken daily by an HIV-negative person, reduces the likelihood of acquiring HIV by more than 90 percent.
BETA wanted to distill some of these important findings by asking some prominent San Francisco Bay Area providers to give us their take on the conference. We asked, “What did you find interesting? What did you find exciting? And, what did you learn?”
KCBS’ Jane McMillan talks with Dr. Deborah Cohan, obstetrician and gynecologist, who runs the UCSF Perinatal HIV Clinic and is Medical Director of HIVE, the Bay Area Perinatal AIDS Center at SF General.
Learn about the roles of PrEP (Pre-Exposure Prophylaxis), PEP (Post-Exposure Prophylaxis), TasP (Treatment as Prevention), male and female condoms, and more.
“We look at the scale-up of PrEP in San Francisco in the United States of America (USA), where comprehensive PrEP services are already changing lives and the shape of the epidemic.”
“…having HIV, or having a partner living with HIV, shouldn’t change our opinions about who has the right to have a child.”
“But I think to myself, well, that’s our problem. That’s a fixable problem. We need to create a story about inclusion, about what’s possible. That’s just as important as the work to get the science to make it possible.”
In 1991, during the peak of the HIV/AIDS epidemic, 1650 babies were born with HIV in the United States. By 2010, that number had declined to 162.
“Shannon’s enthusiasm for the well-being of others has helped build healthy and loving families in more ways than one.”